Thilo Hanemann is report author and Director of Rhodium Group’s cross-border investment practice. His research assesses new trends in global trade and capital flows, related policy developments, and the political and commercial dynamics of specific transactions. Mr. Hanemann’s most recent work focuses on the evolution of China’s international investment position, and the economic and policy implications of this new trend. He is a frequent speaker and commentator on China’s outward investment and has published numerous reports and articles on the topic. He is also a Senior Policy Fellow at the Mercator Institute for China Studies, Europe’s biggest China think tank, located in Berlin.

Stephen A. Orlins has been President of the National Committee since 2005. Previously, he was Managing Director of Carlyle Asia and Chair of cable and internet provider Taiwan Broadband Communications; a senior advisor to leveraged buyout firm AEA Investors; Managing Director of Lehman Brothers; and President of Lehman Brothers Asia. From 1976 to 1979, he was a member of the U.S. State Department’s legal team that helped establish diplomatic relations with China. Mr. Orlins graduated magna cum laude from Harvard College and earned a law degree from Harvard Law School. He speaks Mandarin and is a member of the Council on Foreign Relations.

Tom Chang is President of East West Bank (China) Ltd, responsible for corporate management, strategic planning, business development and executive leadership in China. He joined East West Bank in 2010 and has been country president for China since 2015. He is a professional banking executive with 25 years of experience and a proven track record in areas of new market expansion, sales management, strategic planning, corporate banking, aviation finance, cross border banking, commercial real estate lending, construction lending, international trade finance, branch management, credit risk management, technology lending and wealth management investments.

As Head of China and Senior Vice President of FedEx Express, Eddy Chan oversees the many operations of FedEx Express in this rapidly growing and increasingly vital market. Chan is responsible for the overall tactical planning and administration of the strategically important China region, headquartered in the booming city of Shanghai. Since joining FedEx as an Account Executive in Hong Kong in 1985, Chan has developed an impressive breadth of experience from his roles in many divisions. After being promoted to station manager in Hong Kong, Chan moved into sales. He started out as a District Sales Manager in Hong Kong, and eventually became Managing Director of Sales for the Mid-Pacific region. After moving back into operations, serving as Managing Director of Operations for FedEx Taiwan, Chan became Vice President and General Manager of China and later Regional Vice President and General Manager of China and Taiwan, eventually adding the whole mid-Pacific region to his domain.

Chan has received numerous honors. He serves as a consultant to the Shanghai World Trade Organization Consultation Center and the China Maritime Arbitration Commission. He has served as Vice President of the China Federation of Logistics and Purchasing, and Vice Chair of Shanghai Express Industry Association. In 2011, Chan received the “Magnolia Award” from the Shanghai Municipal Government. In 2014, Chan received the “2014 CSR Innovator” award from CBN Weekly. Chan received a Bachelor of Arts in history from the University of Hong Kong and an Executive MBA from the Kellogg School of Management at Northwestern University in conjunction with the Hong Kong University of Science and Technology.

David He joined Fosun Healthcare Holdings in April 2017. Founded in 1992 in Shanghai, Fosun is one of China’s most successful companies. Fosun’s mission is the “creating a happiness ecosystem for success, bring a healthy, happy and wealthy life to families around the world.” The company has many overseas investments, including in the United States.

David is responsible for the global development of Fosun’s healthcare consumer business. He has an MBA from Australia Graduate School of Management and a BS in biochemistry from New South Wales University. He has over 20 years of M&A experience with McKinsey, ABINBEV and Johnson & Johnson.